Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

37.27
+3.199.36%
Post-market: 37.920.6500+1.74%19:30 EDT
Volume:199.24K
Turnover:7.24M
Market Cap:632.36M
PE:-2.19
High:37.34
Open:34.25
Low:34.25
Close:34.08
52wk High:74.07
52wk Low:11.50
Shares:16.97M
Float Shares:5.64M
Volume Ratio:1.61
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.9879
EPS(LYR):-17.3000
ROE:-646.34%
ROA:1.19%
PB:-2.15
PE(LYR):-2.15

Loading ...

DOJ Expands Antitrust Probe of Claritev, Bloomberg Reports

MT Newswires Live
·
Jul 15

DOJ expands Claritev antitrust investigation, Bloomberg reports

TIPRANKS
·
Jul 15

Claritev drops 13% to $25.93 following Bloomberg report

TIPRANKS
·
Jul 15

Multiplan Launches Share Buyback Program for up to 5 Million Common Shares

Reuters
·
Jun 26

Claritev management participates in Truist Securities Healthcare Disruptors & Digital Health Conference

Reuters
·
Jun 24

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH), GoodRx Holdings (GDRX) and Claritev (CTEV)

TIPRANKS
·
Jun 23

Claritev Corp - Antitrust Grand Jury Proceeding Closed; Claritev Not Under Criminal Investigation as of June 17, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 23

Claritev Corp - Received Civil Investigative Demand From DOJ on May 19; Cooperating Fully With DOJ - SEC Filing

THOMSON REUTERS
·
Jun 23

Claritev says DOJ closes antitrust grand jury probe, no criminal investigation pending

Reuters
·
Jun 23

Claritev says No Surprises Act dispute system drives $5 billion in costs as filings top 5 million

Reuters
·
Jun 15

Claritev SVP, Chief People Officer Carol Nutter acquires USD 24,856 in common shares

Reuters
·
Jun 11

U.S. RESEARCH ROUNDUP-Broadcom, CrowdStrike, Home Depot

Reuters
·
Jun 04

Claritev price target lowered to $61 from $90 at Piper Sandler

TIPRANKS
·
Jun 04

Claritev Initiated at Buy by Canaccord Genuity

Dow Jones
·
May 29

Canaccord Genuity Initiates Claritev at Buy With $32 Price Target

MT Newswires Live
·
May 29

Multiplan publishes 2025 annual report

Reuters
·
May 21

Claritev director John Michael Prince acquires 10,000 shares for $160,000

Reuters
·
May 20

Claritev CEO Travis Dalton buys 20,920 shares valued at $259,094.40

Reuters
·
May 20

Claritev (CTEV) Receives a Buy from Barclays

TIPRANKS
·
May 19

Sector Update: Healthcare

MT Newswires Live
·
May 19